Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate,atorvastatin calcium trihydrate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate,atorvastatin calcium trihydrate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate,atorvastatin calcium trihydrate -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - .alpha.1-proteinase inhibitor human (unii: f43i396ois) (.alpha.1-proteinase inhibitor human - unii:f43i396ois) - .alpha.1-proteinase inhibitor human 1 g in 50 ml - glassia is an alpha1 -proteinase inhibitor (human), indicated for chronic augmentation and maintenance therapy in individuals with clinically evident emphysema due to severe hereditary deficiency of alpha1 -pi, also known as alpha1 -antitrypsin (aat) deficiency. limitations of use : - the effect of augmentation therapy with glassia or any alpha1 -pi product on pulmonary exacerbations and on the progression of emphysema in alpha1 -pi deficiency has not been conclusively demonstrated in randomized, controlled clinical trials. - clinical data demonstrating the long-term effects of chronic augmentation and maintenance therapy of individuals with glassia are not available. - glassia is not indicated as therapy for lung disease in patients in whom severe alpha1 -pi deficiency has not been established. glassia is contraindicated in: - immunoglobulin a (iga) deficient patients with antibodies against iga. - individuals with a history of anaphylaxis or other severe systemic reaction to alpha1 -pi products. risk summar

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

walmart stores - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves heartburn sour stomach acid indigestion upset stomach due to these symptoms

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

target corporation - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves heartburn sour stomach acid indigestion upset stomach due to these symptoms warnings do not use if you have ever had an allergic reaction to this product or any of its ingredients

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

topco associates - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves - heartburn - sour stomach - acid indigestion - upset stomach due to these symptoms

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

cvs pharmacy - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves heartburn sour stomach acid indigestion upset stomach due to these symptoms

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

meijer distribution inc. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves heartburn sour stomach acid indigestion upset stomach due to these symptoms

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

par pharmaceutical companies, inc. - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ]. - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see post-marketing experience (6.2) ]. pregnancy category d [see warnings and precautions